KREBSBIO — Krebs Biochemicals And Industries Income Statement
0.000.00%
Last trade - 00:00- IN₹1.90bn
- IN₹4.02bn
- IN₹433.12m
Annual income statement for Krebs Biochemicals And Industries, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 537 | 597 | 521 | 504 | 433 |
| Cost of Revenue | |||||
| Gross Profit | 83.4 | -81.9 | 117 | 218 | 378 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 764 | 1,000 | 745 | 659 | 650 |
| Operating Profit | -227 | -403 | -223 | -155 | -217 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -284 | -445 | -247 | -197 | -269 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -284 | -445 | -247 | -197 | -269 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -284 | -445 | -247 | -197 | -269 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -284 | -445 | -247 | -197 | -269 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -14.5 | -20.7 | -11.3 | -9.15 | -12.5 |